We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Filters applied:

Search Results

Showing 1-20 of 664 results
  1. Histidine re-sensitizes pediatric acute lymphoblastic leukemia to 6-mercaptopurine through tetrahydrofolate consumption and SIRT5-mediated desuccinylation

    Despite progressive improvements in the survival rate of pediatric B-cell lineage acute lymphoblastic leukemia (B-ALL), chemoresistance-induced...

    Na Dong, Hui-Xian Ma, ... Xiu-Li Ju in Cell Death & Disease
    Article Open access 14 March 2024
  2. TPEN selectively eliminates lymphoblastic B cells from bone marrow pediatric acute lymphoblastic leukemia patients

    B-cell acute lymphoblastic leukemia (B-ALL) is a hematologic disorder characterized by the abnormal proliferation and accumulation of immature...

    M. Mendivil-Perez, C. Velez-Pardo, ... Marlene Jimenez-Del-Rio in BioMetals
    Article 30 May 2022
  3. NSD2 E1099K drives relapse in pediatric acute lymphoblastic leukemia by disrupting 3D chromatin organization

    Background

    The NSD2 p.E1099K (EK) mutation is shown to be enriched in patients with relapsed acute lymphoblastic leukemia (ALL), indicating a role in...

    Sonali Narang, Nikki A. Evensen, ... William L. Carroll in Genome Biology
    Article Open access 04 April 2023
  4. The impact of exosomes derived from B-cell acute lymphoblastic leukemia as a growth factor on bone marrow mesenchymal stromal cells

    Background The incidence of various types of cancers, including leukemia, is on the rise and many challenges in both drug resistance and...

    Mozhgan Amirpour, Bentolhoda Kuhestani-Dehaghi, ... Mehdi Allahbakhshian-Farsani in Molecular Biology Reports
    Article 14 June 2024
  5. Advancements in small interfering RNAs therapy for acute lymphoblastic leukemia: promising results and future perspectives

    Acute lymphoblastic leukemia (ALL) is the most common type of cancer among children, presenting significant healthcare challenges for some patients,...

    Amirhossein Rastgar, Setare Kheyrandish, ... Mahdi Ghorbani in Molecular Biology Reports
    Article 14 June 2024
  6. The IKAROS Transcription Factor Gene IKZF1 as a Critical Regulator in the Pathogenesis of Childhood Acute Lymphoblastic Leukemia: Insights from a Bangladeshi Population

    The IKZF1 transcription factor gene plays a pivotal role in the commitment of multipotent progenitors to common lymphoid progenitors during...

    Nurun Nahar Nila, Sonia Tamanna, ... Md. Zakir Hossain Howlader in Indian Journal of Clinical Biochemistry
    Article 04 April 2024
  7. Graft failure after allogeneic hematopoietic stem cell transplantation in pediatric patients with acute leukemia: autologous reconstitution or second transplant?

    Background

    Graft failure (GF) is a rare but serious complication after allogeneic hematopoietic stem cell transplantation (HSCT). Prevention of graft...

    Tahereh Rostami, Mohammad Reza Rostami, ... Amir Kasaeian in Stem Cell Research & Therapy
    Article Open access 22 April 2024
  8. The potential role of renin angiotensin system in acute leukemia: a narrative review

    Acute leukemias (ALs) are the most common cancers in pediatric population. There are two types of ALs: acute lymphoblastic leukemia (ALL) and acute...

    Kacio Roger Portes e Silva, Eugênia Maia Nogueira, ... Ana Cristina Simões e Silva in Molecular Biology Reports
    Article 21 June 2024
  9. Disseminated Basidiobolomycosis Caused by Basidiobolus omanensis in a Child with Acute Lymphoblastic Leukemia (ALL). Case Report and Literature Review

    Basidiobolomycosis is an uncommon fungal infection caused by the genus Basidiobolus . In immunocompetent children, it usually causes cutaneous...

    Laila Al Yazidi, Sharifa Al Sinani, ... Abdullah M. S. Al Hatmi in Mycopathologia
    Article Open access 17 January 2024
  10. Acute lymphoblastic leukemia displays a distinct highly methylated genome

    DNA methylation is tightly regulated during development and is stably maintained in healthy cells. In contrast, cancer cells are commonly...

    Sara Hetzel, Alexandra L. Mattei, ... Alexander Meissner in Nature Cancer
    Article Open access 19 May 2022
  11. CircFBXW7 inhibits the tumorigenesis of T-cell acute lymphoblastic leukemia through modulating miR-494-3p/SOX1 axis

    T-cell acute lymphoblastic leukemia (T-ALL) is a type of leukemia with high malignant behaviors, which seriously threatens the health of people. It...

    Cong Luo, Jun-Jun Li, ... Xing-Xing Long in Cell Death Discovery
    Article Open access 10 May 2022
  12. PKA inhibition kills l-asparaginase-resistant leukemic cells from relapsed acute lymphoblastic leukemia patients

    Despite the success in treating newly diagnosed pediatric acute lymphoblastic leukemia (aLL), the long-term cure rate for the 20% of children who...

    Jung Kwon Lee, Xidi Wang, ... Ki-Young Lee in Cell Death Discovery
    Article Open access 27 May 2024
  13. Histone acetylation by HBO1 (KAT7) activates Wnt/β-catenin signaling to promote leukemogenesis in B-cell acute lymphoblastic leukemia

    B-cell acute lymphoblastic leukemia (B-ALL) is an aggressive hematological disorder with a dismal prognosis. The dysregulation of histone acetylation...

    Hao Wang, Yingqi Qiu, ... Yuhua Li in Cell Death & Disease
    Article Open access 04 August 2023
  14. The Diverse Roles of ETV6 Alterations in B-Lymphoblastic Leukemia and Other Hematopoietic Cancers

    Genetic alterations of the repressive ETS family transcription factor gene ETV6 are recurrent in several categories of hematopoietic malignancy,...
    Alexander C. Monovich, Aishwarya Gurumurthy, Russell J. H. Ryan in Transcription factors in blood cell development
    Chapter 2024
  15. KLF9 promotes autophagy and apoptosis in T-cell acute lymphoblastic leukemia cells by inhibiting AKT/mTOR signaling pathway

    Background

    T -cell acute lymphoblastic leukemia (T-ALL) is considered a malignant tumor with a high mortality rate. To combat this disease, exploring...

    Jie Zhao, Shaolong He, ... Weiwei Tian in Molecular & Cellular Toxicology
    Article 23 August 2022
  16. Knockout KHDRBS3 inhibits cell proliferation and glucocorticoid resistance in acute lymphoblastic leukemia

    Background

    Drug resistance is one of the major causes of the acute lymphoblastic leukemia (ALL) relapse. Although KH RNA-binding domain containing,...

    Xincui Lu, Li Ma, Yufang Yuan in Molecular & Cellular Toxicology
    Article 01 October 2022
  17. Ectopic expression of a combination of 5 genes detects high risk forms of T-cell acute lymphoblastic leukemia

    Background

    T cell acute lymphoblastic leukemia (T-ALL) defines a group of hematological malignancies with heterogeneous aggressiveness and highly...

    Li-Jun Peng, Yue-Bo Zhou, ... Jian-Qing Mi in BMC Genomics
    Article Open access 24 June 2022
  18. Somatic FOXC1 insertion mutation remodels the immune microenvironment and promotes the progression of childhood acute lymphoblastic leukemia

    Acute lymphoblastic leukemia (ALL) is the most common malignant hematological diseases in children. An immunosuppressive microenvironment,...

    Yaping Wang, Xiaopeng Ma, ... Yongjun Fang in Cell Death & Disease
    Article Open access 03 May 2022
  19. The Molecular and Biological Function of MEF2D in Leukemia

    Myocyte enhancer factor 2 (MEF2) is a key transcription factor (TF) in skeletal, cardiac, and neural tissue development and includes four isoforms:...
    Chapter 2024
  20. Association of TP53 gene polymorphisms with the risk of acute lymphoblastic leukemia in Moroccan children

    Background

    TP53 gene plays a pivotal role in maintaining genetic stability and prevention of malignancies. Alterations of this gene are implicated in...

    Hanaa Skhoun, Mohammed Khattab, ... Jamila El Baghdadi in Molecular Biology Reports
    Article 15 June 2022
Did you find what you were looking for? Share feedback.